Gary A. Abrams

3.5k citations
31 papers · 1.7k · 1 hit paper · h-index 17

Impact in

  • Hepatology top 2%
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment

Papers in

    • Liver Disease Diagnosis and Treatment 24
    • Liver Disease and Transplantation 8
    • Hepatitis C virus research 4
    • Liver Diseases and Immunity 4

Gary A. Abrams

28 papers receiving 1.6k citations

Gary A. Abrams's Hit Papers

Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial 2023 · 146 citations
1460+1+2Years since publication4080120

Peers

Gary A. Abrams
Comparison fields: 5 of 94
  • Hepatology 444
  • Epidemiology 1.2k
  • Endocrinology, Diabetes and Metabolism 558
  • Pathology and Forensic Medicine 343
  • Physiology 309
Replace Ibrahim Mostafa with:
Ibrahim Mostafa Egypt
Münevver Demir Germany
Natsu Fukui United States
Dante Romagnoli Italy
Bienvenido Gra‐Oramas Cuba
Elnaz Ehteshami Afshar Canada
David Ka‐Wai Yeung Hong Kong
F. Pons‐Romero Spain
Marika Holmqvist Sweden
Thomas G. Cotter United States
Gary A. Abrams relative to Ibrahim Mostafa Egypt Ibrahim Mostafa's profile →
Citations per field
00.5×
Ibrahim Mostafa · 1×
Citations per year

Countries citing papers authored by Gary A. Abrams

Since Specialization
Citations

This map shows the geographic impact of Gary A. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Abrams more than expected).

Fields of papers citing papers by Gary A. Abrams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Abrams. The network helps show where Gary A. Abrams may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary A. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary A. Abrams Line = papers co-authored together Gary A. Abrams links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008237
2 2008225
3 2005161
4 2004147
5
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
Hit paper breakdown →
2023146
6 2007109
7 2010103
8 199888
9 200885
10 200761
11 200652
12 200846
13 200041
14 202233
15 201826
16 201023
17 202016
18 202216
19 201611
20 200811

About Gary A. Abrams

Gary A. Abrams is a scholar working on Epidemiology, Hepatology, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (8 papers), Diet, Metabolism, and Disease (6 papers), Alcohol Consumption and Health Effects (6 papers), Pancreatitis Pathology and Treatment (5 papers), Hepatitis C virus research (4 papers), Liver Diseases and Immunity (4 papers) and Cardiovascular Disease and Adiposity (3 papers). The work is most often cited by research in Hepatology (444 citations), Epidemiology (1.2k citations), Endocrinology, Diabetes and Metabolism (558 citations), Pathology and Forensic Medicine (343 citations) and Physiology (309 citations). Gary A. Abrams has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Ronald H. Clements, Audrey J. Lazenby, Sachin Kunde, Shannon M. Bailey, Sudheer K. Mantena, Kelly K. Andringa, Adrienne L. King, Heather B. Eccleston, Bao Luo and Michael B. Fallon. Their work appears in journals such as Obesity Surgery, Hepatology, Gastroenterology, The American Journal of Gastroenterology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact